ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs MXN
18.1108
0.00%
Brent Oil
84.39
0.00%
Bitcoin
64,419.69
0.27%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) Noticias

ZNTL

Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZNTL
FechaHoraFuenteTítuloSímboloCompañía
18/06/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development ProgramNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/06/202417:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/06/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
30/05/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/05/202406:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/05/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of DirectorsNASDAQ:ZNTLZentalis Pharmaceuticals Inc
23/05/202416:01GlobeNewswire Inc.Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:ZNTLZentalis Pharmaceuticals Inc
14/05/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/05/202406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/05/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/04/202415:05GlobeNewswire Inc.Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/02/202416:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/02/202416:14Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZNTLZentalis Pharmaceuticals Inc
28/02/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
27/02/202406:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
27/02/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202418:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
12/02/202419:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
12/02/202419:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
25/01/202406:00GlobeNewswire Inc.Zentalis Pharmaceuticals Strengthens Management Team with Key AppointmentsNASDAQ:ZNTLZentalis Pharmaceuticals Inc
08/01/202406:00Business WireImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology PlatformNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/01/202419:19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/11/202306:00GlobeNewswire Inc.Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD CowenNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/11/202306:18GlobeNewswire Inc.Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/09/202306:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
09/08/202306:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/08/202315:28GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/08/202306:00GlobeNewswire Inc.Zentalis Pharmaceuticals Appoints Kimberly Freeman as Chief Strategy OfficerNASDAQ:ZNTLZentalis Pharmaceuticals Inc
20/06/202315:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZNTL

Su Consulta Reciente

ASX
TECH
Global X Management AUS
BIT
P207Y6
NLBNPIT207Y6 20240620 18...
LSE
OMXS
Omx Stckhlm Cp
BMF
WINJ26
WINJ26 - Abril 2026
NASDAQI
XNDXEURMH
XNDX EUR Monthly Currenc...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados